In breast cancer, while bulk RNAseq was found to closely resemble single-cell profiling, particularly in the Luminal and HER2-enriched subtypes, the single-cell approach helped to define other characteristics important to the understanding of cancer biology [14]. Here, ERBB2 is linked to breast cancer.